OK-432 therapy for lymphangiomas

Authors

Richard J.H. Smith, The Department of Otolaryngology
Diane K. Burke
Yutaha Sato, University of Iowa
Rolland I. Poust
Ken Kimura, The Department of Otolaryngology
Nancy M. Bauman, University of Iowa

Document Type

Journal Article

Publication Date

1-1-1996

Journal

Archives of Otolaryngology - Head and Neck Surgery

Volume

122

Issue

11

DOI

10.1001/archotol.1996.01890230041009

Abstract

Objective: To assess the efficacy of OK-432 sclerotherapy in the treatment of lymphangiomas. Design: Nonrandomized trial; follow up, 4 to 29 months. Setting: Academic tertiary referral medical center. Patients: Six children with presumed lymphangiomas; age range at initial treatment, 1 month to 7 years 10 months. Intervention: Fluoroscopically guided cyst aspiration, cystography, and injection of OK-432. Outcome Measures: Clinical and radiographic comparisons before and after therapy. Results: Complete response in 2 macrocystic lymphangiomas; no response in 3 microcystic lymphangiomas; and no response in 1 venous malformation. Conclusion: OK-432 sclerotherapy may be effective treatment for macrocystic lymphangiomas.

APA Citation

Smith, R., Burke, D., Sato, Y., Poust, R., Kimura, K., & Bauman, N. (1996). OK-432 therapy for lymphangiomas. Archives of Otolaryngology - Head and Neck Surgery, 122 (11). http://dx.doi.org/10.1001/archotol.1996.01890230041009